Rallybio Stock Based Compensation vs Capital Expenditures Analysis

RLYB Stock

USD 1.12 0.03 2.75%

Rallybio Corp financial indicator trend analysis is much more than just breaking down Rallybio Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rallybio Corp is a good investment. Please check the relationship between Rallybio Corp Stock Based Compensation and its Capital Expenditures accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rallybio Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.

Stock Based Compensation vs Capital Expenditures

Stock Based Compensation vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rallybio Corp Stock Based Compensation account and Capital Expenditures. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Rallybio Corp's Stock Based Compensation and Capital Expenditures is -0.68. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Rallybio Corp, assuming nothing else is changed. The correlation between historical values of Rallybio Corp's Stock Based Compensation and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Rallybio Corp are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Stock Based Compensation i.e., Rallybio Corp's Stock Based Compensation and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

-0.68

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Capital Expenditures

Capital Expenditures are funds used by Rallybio Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Rallybio Corp operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Rallybio Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rallybio Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rallybio Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.The current year's Tax Provision is expected to grow to 1,208, whereas Selling General Administrative is forecasted to decline to about 18.8 M.

	2021	2022	2023	2024 (projected)
Interest Income	54K	2.0M	5.8M	6.1M
Net Interest Income	44K	2.0M	5.8M	6.1M

Interest Income Net Interest Income

Rallybio Corp fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Long Term Investments	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Capital Stock
Total Assets		0.87	0.87	0.83	-0.97	0.8	0.86	-0.72	-0.75	0.3	0.72	0.74	1.0	0.34	-0.06	0.55	0.85	-0.02	0.83	-0.36	0.83	1.0	1.0	-0.22	0.91	0.74
Other Current Liab	0.87		1.0	0.89	-0.87	0.91	0.99	-0.32	-0.91	0.19	0.32	0.64	0.86	0.57	-0.37	0.51	0.97	-0.32	0.89	-0.62	0.99	0.87	0.86	-0.5	0.86	0.96
Total Current Liabilities	0.87	1.0		0.85	-0.89	0.88	0.98	-0.32	-0.91	0.28	0.32	0.59	0.86	0.57	-0.3	0.46	0.95	-0.25	0.85	-0.67	0.98	0.87	0.86	-0.43	0.84	0.94
Total Stockholder Equity	0.83	0.89	0.85		-0.76	0.93	0.91	-0.44	-0.77	-0.18	0.44	0.9	0.82	0.39	-0.59	0.7	0.95	-0.55	1.0	-0.23	0.91	0.83	0.82	-0.7	0.92	0.85
Other Liab	-0.97	-0.87	-0.89	-0.76		-0.81	-0.83	0.65	0.82	-0.38	-0.65	-0.64	-0.97	-0.52	0.01	-0.58	-0.86	-0.04	-0.76	0.44	-0.83	-0.97	-0.97	0.16	-0.91	-0.79
Net Tangible Assets	0.8	0.91	0.88	0.93	-0.81		0.89	-0.3	-0.93	-0.16	0.29	0.82	0.79	0.66	-0.59	0.75	0.96	-0.55	0.94	-0.33	0.92	0.8	0.8	-0.71	0.92	0.94
Property Plant And Equipment Net	0.86	0.99	0.98	0.91	-0.83	0.89		-0.33	-0.85	0.16	0.33	0.67	0.85	0.43	-0.4	0.44	0.95	-0.36	0.91	-0.61	0.98	0.86	0.85	-0.53	0.83	0.91
Net Debt	-0.72	-0.32	-0.32	-0.44	0.65	-0.3	-0.33		0.15	-0.28	-1.0	-0.58	-0.74	0.14	-0.33	-0.44	-0.38	-0.35	-0.45	-0.22	-0.27	-0.72	-0.74	-0.22	-0.63	-0.16
Retained Earnings	-0.75	-0.91	-0.91	-0.77	0.82	-0.93	-0.85	0.15		-0.08	-0.14	-0.57	-0.74	-0.83	0.42	-0.62	-0.91	0.37	-0.77	0.57	-0.91	-0.75	-0.74	0.54	-0.82	-0.96
Accounts Payable	0.3	0.19	0.28	-0.18	-0.38	-0.16	0.16	-0.28	-0.08		0.28	-0.4	0.31	0.0	0.79	-0.38	0.02	0.81	-0.18	-0.62	0.11	0.3	0.3	0.72	0.0	0.05
Cash	0.72	0.32	0.32	0.44	-0.65	0.29	0.33	-1.0	-0.14	0.28		0.58	0.73	-0.14	0.33	0.44	0.38	0.35	0.45	0.22	0.27	0.72	0.73	0.23	0.63	0.16
Non Current Assets Total	0.74	0.64	0.59	0.9	-0.64	0.82	0.67	-0.58	-0.57	-0.4	0.58		0.73	0.23	-0.56	0.79	0.76	-0.53	0.9	0.17	0.66	0.74	0.74	-0.65	0.86	0.61
Cash And Short Term Investments	1.0	0.86	0.86	0.82	-0.97	0.79	0.85	-0.74	-0.74	0.31	0.73	0.73		0.34	-0.04	0.55	0.84	0.0	0.82	-0.35	0.81	1.0	1.0	-0.2	0.91	0.73
Common Stock Shares Outstanding	0.34	0.57	0.57	0.39	-0.52	0.66	0.43	0.14	-0.83	0.0	-0.14	0.23	0.34		-0.33	0.62	0.61	-0.3	0.39	-0.38	0.59	0.34	0.33	-0.4	0.54	0.76
Non Current Liabilities Total	-0.06	-0.37	-0.3	-0.59	0.01	-0.59	-0.4	-0.33	0.42	0.79	0.33	-0.56	-0.04	-0.33		-0.46	-0.48	1.0	-0.59	-0.04	-0.45	-0.06	-0.05	0.99	-0.33	-0.5
Other Current Assets	0.55	0.51	0.46	0.7	-0.58	0.75	0.44	-0.44	-0.62	-0.38	0.44	0.79	0.55	0.62	-0.46		0.69	-0.44	0.7	0.25	0.55	0.54	0.54	-0.55	0.82	0.63
Other Stockholder Equity	0.85	0.97	0.95	0.95	-0.86	0.96	0.95	-0.38	-0.91	0.02	0.38	0.76	0.84	0.61	-0.48	0.69		-0.43	0.95	-0.44	0.98	0.85	0.85	-0.61	0.94	0.97
Total Liab	-0.02	-0.32	-0.25	-0.55	-0.04	-0.55	-0.36	-0.35	0.37	0.81	0.35	-0.53	0.0	-0.3	1.0	-0.44	-0.43		-0.55	-0.08	-0.41	-0.01	-0.01	0.98	-0.29	-0.46
Net Invested Capital	0.83	0.89	0.85	1.0	-0.76	0.94	0.91	-0.45	-0.77	-0.18	0.45	0.9	0.82	0.39	-0.59	0.7	0.95	-0.55		-0.23	0.91	0.83	0.83	-0.7	0.92	0.85
Long Term Investments	-0.36	-0.62	-0.67	-0.23	0.44	-0.33	-0.61	-0.22	0.57	-0.62	0.22	0.17	-0.35	-0.38	-0.04	0.25	-0.44	-0.08	-0.23		-0.59	-0.36	-0.35	0.03	-0.18	-0.57
Property Plant And Equipment Gross	0.83	0.99	0.98	0.91	-0.83	0.92	0.98	-0.27	-0.91	0.11	0.27	0.66	0.81	0.59	-0.45	0.55	0.98	-0.41	0.91	-0.59		0.83	0.82	-0.58	0.86	0.97
Total Current Assets	1.0	0.87	0.87	0.83	-0.97	0.8	0.86	-0.72	-0.75	0.3	0.72	0.74	1.0	0.34	-0.06	0.54	0.85	-0.01	0.83	-0.36	0.83		1.0	-0.21	0.91	0.74
Net Working Capital	1.0	0.86	0.86	0.82	-0.97	0.8	0.85	-0.74	-0.74	0.3	0.73	0.74	1.0	0.33	-0.05	0.54	0.85	-0.01	0.83	-0.35	0.82	1.0		-0.2	0.91	0.73
Common Stock	-0.22	-0.5	-0.43	-0.7	0.16	-0.71	-0.53	-0.22	0.54	0.72	0.23	-0.65	-0.2	-0.4	0.99	-0.55	-0.61	0.98	-0.7	0.03	-0.58	-0.21	-0.2		-0.47	-0.62
Property Plant Equipment	0.91	0.86	0.84	0.92	-0.91	0.92	0.83	-0.63	-0.82	0.0	0.63	0.86	0.91	0.54	-0.33	0.82	0.94	-0.29	0.92	-0.18	0.86	0.91	0.91	-0.47		0.84
Capital Stock	0.74	0.96	0.94	0.85	-0.79	0.94	0.91	-0.16	-0.96	0.05	0.16	0.61	0.73	0.76	-0.5	0.63	0.97	-0.46	0.85	-0.57	0.97	0.74	0.73	-0.62	0.84

Click cells to compare fundamentals

Rallybio Corp Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

AVAV	AeroVironment
ELVN	Enliven Therapeutics
NFLX	Netflix

When determining whether Rallybio Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rallybio Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rallybio Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rallybio Corp Stock:

How To Invest In Rallybio

Details

Is Rallybio Stock a good investment?

Details

What is Rallybio Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rallybio Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rallybio Corp. If investors know Rallybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rallybio Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.78)

Revenue Per Share

0.007

Return On Assets

(0.39)

Return On Equity

(0.67)

The market value of Rallybio Corp is measured differently than its book value, which is the value of Rallybio that is recorded on the company's balance sheet. Investors also form their own opinion of Rallybio Corp's value that differs from its market value or its book value, called intrinsic value, which is Rallybio Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rallybio Corp's market value can be influenced by many factors that don't directly affect Rallybio Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Rallybio Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rallybio Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rallybio Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rallybio Stock Based Compensation vs Capital Expenditures Analysis

Stock Based Compensation vs Capital Expenditures

Stock Based Compensation vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Stock Based Compensation

Capital Expenditures

Rallybio Corp fundamental ratios Correlations

Rallybio Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments

Cash	- 1.0	Net Debt
Net Working Capital	- 0.97	Other Liab
Total Current Assets	- 0.97	Other Liab
Cash And Short Term Investments	- 0.97	Other Liab
Other Liab	- 0.97	Total Assets
Capital Stock	- 0.96	Retained Earnings